Skip to main content

Advertisement

SpringerLink
Log in

Neopterin, ein neuer biochemischer Marker zur klinischen Erfassung zellulärer Immunreaktionen

Neopterin, a new biochemical marker for clinical assessment of cell mediated immune response

  • Übersichten
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

Activated T-lymphocytes represent crucial effector cells. They are pathogenetically involved into various disease states such as allograft rejection or viral infection. So far their assessment is laborious and rarely possible in clinical routine. In this review article we present the compount neopterin as a new biochemical marker for the in vivo and in vitro detection of activated T-lymphocytes. Our main finding was that in vitro as well as in vivo stimulation of T-lymphocytes with foreign and chemically or virally modified autologous cells in invariably associated with increased neopterin production. It thus appeared that neopterin might represent a potential marker for biochemical monitoring of diseases caused by or associated with T-lymphocyte activation. Our clinical experience with neopterin determination in allograft rejection and in infectious or autoimmune states strongly support this view. We conclude that evaluation of neopterin represents a useful and simple tool for the biochemical monitoring of immunological and/or malignant states.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Literatur

  1. Bichler A, Hetzel H, Fuchs D, Hausen A, Reibnegger G, Wachter H (1982) Significance of urinary neopterin in gynecology and obstetrics: oncology, pregnancy, amniotic fluid. In: Wachter H, Curtis HCh, Pfleiderer W (eds) Biochemical and clinical aspects of pteridines. Walter de Gruyter, Berlin New York, pp 141–156

    Google Scholar 

  2. Bichler A, Fuchs D, Hausen A, Hetzel H, Reibnegger G, Wachter H (1983) Measurement of urinary neopterin in normal, pregnant and non-pregnant women and in women with benign and malignant genital tract neoplasms. Arch Gynecol (in press)

  3. Cremer-Bartels G, Ebels I (1980) Pteridines as nonretinal regulators of light-dependent melatonin biosynthesis. Proc Natl Acad Sci 77:2415–2418

    Google Scholar 

  4. Danks DM, Cotton RGH, Schlesinger P (1975) Tetrahydrobiopterin treatment of variant forms of phenylketonuria. Lancet II:1043

    Google Scholar 

  5. Evans RL, Faldetta TJ, Humphreys RE, Pratt DM, Yunis EJ, Schlossman SF (1978) Peripheral human T cells sensitized in mixed leucocyte culture synthesize and express I a like antigens. J Exp Med 148:114–1445

    Google Scholar 

  6. Fuchs D, Hausen A, Huber Ch, Margreiter R, Reibnegger G, Spielberger M, Wachter H (1982) Pteridinausscheidung als Marker für alloantigen-induzierte Lymphozytenproliferation. Hoppe-Seyler's Z Physiol Chem 363:661–664

    Google Scholar 

  7. Fuchs D, Hausen A, Kofler M, Kosanowski H, Reibnegger G, Wachter H (1983) Neopterin as index of immune response in patients suffering from tuberculosis (in preparation)

  8. Fukushima T, Shiota T (1972) Pteridines in human urine. J Biol Chem 247:4549–4556

    Google Scholar 

  9. Grünewald K, Huber H, Fuchs D, Hausen A, Reibnegger G, Wachter H (1982) Neopterin estimations in benign and malignant hematological disorders and their connections with tumor staging and remissions. In: Wachter H, Curtius HCh, Pfleiderer W (eds) Biochemical and clinical aspects of pteridines. Walter de Gruyter, Berlin New York, pp 173–206

    Google Scholar 

  10. Guttman HN (1964) Crithidia assays for unconjugated pteridines. In: Pfleiderer W, Taylor EC (eds) Chemistry and biology of pteridines. Pergamon Press, Oxford, pp 255–266

    Google Scholar 

  11. Hausen A, Fuchs D, Grünewald K, König K, Wachter H (1982) Urinary neopterin in the assessment of lymphoid and myeloid neoplasia, and neopterin levels in haemolytic anaemia and benign monoclonal gammopathy. Clin Biochem 15:34–37

    Google Scholar 

  12. Hausen A, Fuchs D, König K, Wachter H (1982) Determination of neopterin in human urine by reversed phase high performance liquid chromatography. J Chromatogr 227:61–60

    Google Scholar 

  13. Hausen A, Wachter H (1982) Pteridines in the assessment of neoplasia. J Clin Chem Clin Biochem 20:593–602

    Google Scholar 

  14. Huber Ch, Asamer H, Kurz R, Huber H, Braunsteiner H (1971) Zytologischer Immunglobulinnachweis an DNS-synthetisierenden Blutlymphozyten von Patienten mit Virusinfektionen. Acta Haematol 45:23–28

    Google Scholar 

  15. Huber Ch, Huber H, Gföller A, Michlmayr G, Braunsteiner H (1971) DNS-synthetisierende Blutlymphozyten bei Karzinompatienten. Med Klinik 43:1441–1445

    Google Scholar 

  16. Huber Ch, Michlmayr G, Falkensammer M (1975) Increased proliferation of T-lymphocytes in the blood of patients with Hodgkin's disease. Clin Exp Immunol 21:47–53

    Google Scholar 

  17. Huber Ch, Michlmayr G (1977) Surface markers on lymphoid cells, blood leucocytes, function and use in therapy. In: Högman CF, Fischer-Lindal K, Wigzell H (eds) Reklam, pp 1–6

  18. Huber Ch, Fink U, Leibold W, Schmalzl F, Peterson PA, Klareskog L, Braunsteiner H (1981) The role of adherent HLA-DR+ mononuclear cells in autologous and allogeneic MLR. J Immunolog 127:726–731

    Google Scholar 

  19. Huber Ch, Merkenschlager M, Gattringer K, Royston I, Fink U, Braunsteiner M (1982) J Exp Med 155:1222–1227

    Google Scholar 

  20. Huber Ch, Fuchs D, Hausen A, Margreiter R, Reibnegger G, Spielberger M, Wachter H (1983) Pteridines as a new marker to detect human T-cells activated by allogeneic or modified self major histocompatibility complex (MHC) determinants. J Immunolog 130:1047–1050

    Google Scholar 

  21. Kaufman S (1963) The structure of phenylalanine hydroxylation cofactor. Proc Natl Acad Sci 50:1085–1092

    Google Scholar 

  22. Kostron-Krainz Ch, Fuchs D, Hausen A, Reibnegger G, Wachter H (1982) Urinary neopterin evaluation in malignant diseases in childhood. In: Wachter H, Curtius HCh, Pfleiderer W (eds) Biochemical and clinical aspects of pteridines. Walter de Gruyter, Berlin New York, pp 157–171

    Google Scholar 

  23. Loidl P, Fuchs D, Gröbner P, Hausen A, Reibnegger G, Wachter H (1982) Pteridines during growht and differentiation of Physarum polycephalum. In: Wachter H, Curtius HCh, Pfleiderer W (eds) Biochemical and clinical aspects of pteridines. Walter de Gruyter, Berlin New York, pp 257–266

    Google Scholar 

  24. Margreiter R, Fuchs D, Hausen A, Huber Ch, Reibnegger G, Spielberger M, Wachter H (1983) Neopterin as new biochemical marker for early diagnosis of renal allograft rejection. Transplantation (in press)

  25. Niederwieser D, Huber Ch, Lutz D, Weiser G, Theml H, Braunsteiner H (1982) Dichteverteilung menschlicher Lymphozyten: II Verteilungsmuster maligner Lymphozyten und prognostische Signifikanz bei Patienten mit non-Hodgkin's-Lymphomen. Blut 45:385–394

    Google Scholar 

  26. Pirie A, Simpson DM (1946) Preparation of a fluorescent substance from the eye of the dogfish, Squalus acanthias. Biochem 40:14–19

    Google Scholar 

  27. Reibnegger G, Fuchs D, Hausen A, Wachter H, Bichler E, Böheim K (1982) Urinary neopterin in patients with head and neck cancer. In: Wachter H, Curtius HCh, Pfleiderer W (eds) Biochemical and clinical aspects of pteridines. Walter de Gruyter, Berlin New York, pp 207–215

    Google Scholar 

  28. Rembold H, Buschmann L (1963) Untersuchungen über die Pteridine der Bienenpuppe. Liebigs Ann Chem 662:72–82

    Google Scholar 

  29. Rembold H, Heinz G (1971) L-threo-neopterin, the major pterin in Escherichia coli B. Hoppe-Seyler's Z Physiol Chem 352:1271–1272

    Google Scholar 

  30. Rembold H, Gyure WL (1972) Biochemie der Pteridine. Angew Chem 84:1088–1099

    Google Scholar 

  31. Rokos H, Rokos K, Frisius H, Kirstaedter HJ (1980) Altered urinary excretion of pteridines in neoplastic disease. Determination of biopterin, neopterin, xanthopterin and pterin. Clin Chim Acta 105:275–286

    Google Scholar 

  32. Shearen GM, Rehn TG, Garbarino CA (1975) Cell mediated lympholysis of trinitrophenyl-modified autologous lymphocytes. J Exp Med 147:1348–1364

    Google Scholar 

  33. Stea B, Halpern RM, Halpern BC, Smith RA (1981) Urinary excretion levels of unconjugated pterins in cancer patients and normal individuals. Clin Chem Acta 113:231–242

    Google Scholar 

  34. Van der Woerd-de Lange JA, Döhrmann J, Huber Ch, Schick P, Rauert K, Begemann H (1978) DNA-synthesizing T- and non-T-cells in chronic lymphocytic leukemia. Blut 37:319–326

    Google Scholar 

  35. Yanky F, Gorsky T, Gorsky Y, Masucci MG, Klein E (1982) Analysis of tumor biopsy cells by autologous T-lymphocytes activated in mixed cultures and propagated with T-cell growth factors. J Exp Med 155:83–95

    Google Scholar 

  36. Wachter H, Fuchs D, Hausen A, Reibnegger (1983) The role of pteridine in regulation of growth In: The chemistry and biology of pteridines and folic acid derivates. Walter de Gruyter, Berlin New York (in press)

    Google Scholar 

  37. Wachter H, Graßmayr K, Hausen A (1979) Enhanced urinary excretion of 7,8-dihydro-6-hydroxylumazine by mice bearing the Ehrlich-Ascites tumor. Cancer Lett 6:61–66

    Google Scholar 

  38. Wachter H, Hausen A, Reider E, Schweiger M (1980) Pteridine excretion from cells as indicator of cell proliferation. Naturwissenschaften 67:610–611

    Google Scholar 

  39. Wachter H, Hausen A, Graßmayr K (1979) Erhöhte Ausscheidung von Neopterin im Harn von Patienten mit malignen Tumoren und mit Viruserkrankungen. Hoppe-Seyler's Z Physiol Chem 360:1957–1960

    Google Scholar 

  40. Wachter H, Hausen A, Fuchs D, Reibnegger (1982) Importance of pteridines for regulation of growth. In: Wachter H, Curtius HCh, Pfleiderer W (eds) Biochemical and clinical aspects of pteridines. Walter de Gruyter, Berlin New York. pp 277–281

    Google Scholar 

  41. Ziegler I (1960) Tetrahydrobiopterin-Derivat als lichtempfindliche Verbindung bei Amphibien und Insekten. Z Naturforsch 15b: 460–465

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Innere Medizin, Universität Innsbruck, Österreich

    Ch. Huber & D. Niederwieser

  2. Institut für Medizinische Chemie und Biochemie, Universität Innsbruck, Österreich

    D. Fuchs, A. Hausen, G. Reibnegger & H. Wachter

  3. Wallenberg Laboratorium, Universität Uppsala, Schweden

    K. Nilsson

Authors
  1. Ch. Huber
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Fuchs
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Niederwieser
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Hausen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Reibnegger
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. Nilsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H. Wachter
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huber, C., Fuchs, D., Niederwieser, D. et al. Neopterin, ein neuer biochemischer Marker zur klinischen Erfassung zellulärer Immunreaktionen. Klin Wochenschr 62, 103–113 (1984). https://doi.org/10.1007/BF01738700

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01738700

Key words

Search

Navigation